Clinical outcome study of crizotinib in immunohistochemistry-proven echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase fusion gene among Indian patients with adenocarcinoma lung

AIMS: The anaplastic lymphoma kinase (ALK) Break Apart FISH Probe Kit and Ventana anti-ALK (D5F3) CDx immunohistochemistry (IHC) assay are the Food and Drug Administration-approved companion diagnostic for targeted therapy with the ALK inhibitor crizotinib in lung cancers. The aim of this study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Batra, Ullas, Aggarwal, Mohit, Jain, Parveen, Goyal, Pankaj, Yadav, Abhishek, Maheshwari, Udip, Mehta, Anurag
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
ORIGINAL ARTICLE: Lung Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865102/
https://www.ncbi.nlm.nih.gov/pubmed/29600239
http://dx.doi.org/10.4103/sajc.sajc_215_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865102/
https://www.ncbi.nlm.nih.gov/pubmed/29600239
http://dx.doi.org/10.4103/sajc.sajc_215_17

Ejemplares similares